Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

被引：0
作者：
R D Kim
S R Alberts
C Peña
I Genvresse
A Ajavon-Hartmann
C Xia
A Kelly
J E Grilley-Olson
机构：
[1] Moffitt Cancer Center,Department of Gastrointestinal Oncology
[2] Mayo Clinic,Department of Medical Oncology
[3] Bayer HealthCare Pharmaceuticals,Division of Hematology and Oncology
[4] Inc.,undefined
[5] Bayer AG,undefined
[6] University of North Carolina,undefined
来源：
British Journal of Cancer | 2018年 / 118卷
关键词：
copanlisib; gemcitabine; cisplatin; biliary tract cancer; phase Ib trial;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：462 / 470
页数：8
相关论文
共 206 条
[61]  
Kochert K(undefined)undefined undefined undefined undefined-undefined
[62]  
Seidel H(undefined)undefined undefined undefined undefined-undefined
[63]  
Pena C(undefined)undefined undefined undefined undefined-undefined
[64]  
Yin S(undefined)undefined undefined undefined undefined-undefined
[65]  
Hiemeyer F(undefined)undefined undefined undefined undefined-undefined
[66]  
Garcia-Vargas J(undefined)undefined undefined undefined undefined-undefined
[67]  
Childs BH(undefined)undefined undefined undefined undefined-undefined
[68]  
Zinzani PL(undefined)undefined undefined undefined undefined-undefined
[69]  
Ebata T(undefined)undefined undefined undefined undefined-undefined
[70]  
Ercolani G(undefined)undefined undefined undefined undefined-undefined
234567891011